Who would have predicted just a couple of years ago that orthopedics would vie to replace cardiovascular as the hottest deal marketplace in medical devices? For some, the sudden and growing interest in orthopedics is due to the industry's attractive nature: during the past several years, it has been one of the strongest performers, in terms of revenue and stock price growth, and it is one device segment where surgeon prerogative in product selection remains strong. In addition, favorable demographics promises even more: an aging Baby Boomer generation is hitting its 50s and 60s, arriving with both more musculo-skeletal injuries and ailments and an attitude that it wants to live well, not just pain free.
For others, the robust deal activity signals a long-overdue consolidation in an industry that, for all its success, has played...